Adjuvant Global Health Technology Fund, L.P.

Adjuvant Global Health Technology Fund, L.P. serves as a 10% owner of AN2 Therapeutics, Inc., focusing on investments within the healthcare sector. This profile details their SEC Form 4 disclosures, which indicate a pattern of sale activity from November 16, 2023, to January 18, 2024. The firm has reported four transactions, all of which were sales, with the largest move occurring on January 18, 2024, totaling approximately $1.7 million.